Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernature.com
Get the latest updates from Nature Communications - current - nature.com science feeds directly as they happen.
Follow now 1630 followers
Last updated about 1 hour ago
about 1 hour ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56335-6The temporal regulation of intracellular...
about 1 hour ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56808-8Author Correction: Transcription Factor 4...
about 1 hour ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56972-xAuthor Correction: CRISPR screens reveal...
about 1 hour ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56973-wAuthor Correction: Interformer: an interaction-aware...
about 1 hour ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56868-wAuthor Correction: Atlantic Ocean thermal...
about 1 hour ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56969-6Author Correction: Dysregulation of MMP2-dependent...
about 1 hour ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56809-7Author Correction: Isospin competitions and...
about 4 hours ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56609-zA ratiometric gas sensing method...
about 5 hours ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56145-wMercury is a highly toxic...
about 5 hours ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56260-8Pyramidal cells are classically thought...
about 5 hours ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56616-0Thermodynamic simulations, operando synchrotron X-ray...
about 5 hours ago
Nature Communications, Published online: 12 February 2025; doi:10.1038/s41467-025-56729-6In this phase 1/2 trial...